PATENT CLAIM ANALYSIS

Application Number: 16055659
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-08
Patent Classification: ["424", "139100"]

Abstract:
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.

Claim (Index 45):
A method of reversing Nogo-66-induced neurite outgrowth inhibition comprising the step of using an isolated monoclonal anti-Nogo-66 antibody.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.6875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11943770', '14989532', '14013916', '11983775', '12693940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.733369230043456
- 35 USC 102 Novelty (BERT): 0.5650732293388556
- Combined Prediction Score: 0.716539629972996
- Mean Citation Score: 391.015772
- Max Citation Score: 460.20157
- Similarity Product: 337.88172114462554

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test